You are on page 1of 4

HOLY NAME UNIVERSITY

COLLEGE OF HEALTH SCIENCES


NURSING DEPARTMENT
City of Tagbilaran

DRUG STUDY

Name of Patient: MR. LECTURIO Address: USA Impression: SARS-CoV-2 nucleic acid amplification (NAA) assay: positive
AUGUST 29, 2020
Date of Visit / Admission: ______________________________________Ward: COVID
______________________ 8
Room: ___________________ MARRIED
Status: ______________ MALE
63Y/O Sex:_________
Age: ______

CLASSIFICATION:
Date Brand Generic Route & NURSING EVALUATIO
DOSAGE MECHANISM OF INDICATIONS CONTRA INDICATIONS SIDE EFFECTS
Ordered Name Name Frequency RESPONSIBILITIES N
ACTION
8/29/202 Cosaa losartan 50mg, per orem Angiotensin II Type -Hypertension -Contraindicated in Most common: - Monitor patient’s BP
0 r potassiu increase once daily. 1 Receptor patients with closely: lying, sitting,
-dizziness
m to 100mg Blockers. hypersensitivity to drug. standing; and pulse
based on -Nephropathy in -fatigue frequently during initial
BP (per orem patients with type dose adjustment and
response. -chest pain periodically during
B.I.D. may Inhibits 2 diabetes -Concomitant use with
also be vasoconstrictive aliskiren is therapy to evaluate
applicable and aldosterone- contraindicated in effectiveness of
Onset: 6hr for dosage secreting action of diabetic patients. Drug-drug: therapy.
-To reduce risk of
adjustment angiotensin II by stroke in patients -Aliskiren,
Peak: 1-
as needed) blocking with increase risk of
2hr
angiotensin II hypertension and -Use cautiously in renal impairment, - If made into
receptor on the left ventricular patients with impaired hypotension, and suspension by
Prepared by: dcasquejo@hnu.edu.ph

 ‌
Duration: surface of vascular hypertrophy. renal or hepatic hyperkalemia in pharmacist, store in
unknown, smooth muscle and function. diabetic patients refrigerator and shake
some other tissue cells. and those with well before each use.
sources moderate to
say 24hrs severe renal
impairment. - If antihypertensive
effect is inadequate
using once-daily doses,
-Lithium, increase a b.i.d. regimen using
lithium level. the same or increased
Monitor patient total daily dose may
for toxicity. give more satisfactory
response.

-NSAIDs, decrease
antihypertensive Patient teaching:
effects. Monitor
BP and renal
function. -Tell patient to avoid all
salt substitutes; these
products may contain
-Potassium potassium, which can
supplements, cause high potassium
cause level in patients taking
hyperkalemia. losartan and to comply
Monitor patient with other additional
closely. interventions for
hypertension (e.g.
stress management,
Drug-food: weight reduction, etc.).
Medication controls
but does not cure

 ‌
-Salt substitutes hypertension.
containing
potassium, may
cause -Educate patient on
hyperkalemia. adverse reactions;
Monitor patient advise patient to report
closely. all adverse reactions
and to immediately
report swelling of face,
eyes, lips, or tongue or
breathing difficulty.

-Instruct client and


family on proper
technique for BP
monitoring and advise
to check BP daily and to
report significant
changes.

 ‌

You might also like